HEALTHCARE
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEMS MARKET GLOBAL FORECAST TO 2020
REPORT CODE MD 3966
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEMS MARKET GLOBAL FORECAST TO 2020 By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), By Application (Respiratory, Cardiac, ECPR), By Geography
REPORT OVERVIEW 1.1
OBJECTIVES OF THE STUDY
•
Extracorporeal membrane oxygenation (ECMO) systems are life supports that take over the function of the lungs or sometimes the heart, outside of a patient’s body. The procedure is the backbone of the treatment of neonatal, pediatric, and adult patients with life threatening respiratory and/or cardiac failure.
•
ECMO is most commonly used in neonatal intensive-care units for newborns with pulmonary distress. It is around 75% effective in saving the life of such newborns. Today, technological advances have led to increased research and utilization of this technology in adult patients with severe respiratory ailments as well. The number of adults for whom ECMO support is used is increasing dramatically. This was more evident during the global H1N1 pandemic, which broke out in 2009 to 2011 and tailed to 2012.
•
ECMO is used in case of respiratory failure, hypoxemia, and pulmonary edema-an abnormal build-up of fluid in the lungs, Congenital Diaphragmatic Hernia (CDH), and Primary Pulmonary Hypertension of the New-Born (PPHN)-including idiopathic PPHN, respiratory distress syndrome, group B streptococcal sepsis, and asphyxia. Although it is expensive and offered in limited settings, ECMO is likely to be increasingly used for adults in the coming years. This increase in use can be attributed to the rising incidences of cardiac diseases as well as the increasing number of cardiac surgeries and heart and lung transplants performed globally.
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
1